KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Tax Provisions (2017 - 2025)

Historic Tax Provisions for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to -$16.0 million.

  • Elanco Animal Health's Tax Provisions fell 10820.51% to -$16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$52.0 million, marking a year-over-year decrease of 12512.08%. This contributed to the annual value of $150.0 million for FY2024, which is 31666.67% up from last year.
  • Latest data reveals that Elanco Animal Health reported Tax Provisions of -$16.0 million as of Q3 2025, which was down 10820.51% from $14.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Tax Provisions high stood at $195.0 million for Q3 2024, and its period low was -$43.0 million during Q4 2024.
  • Moreover, its 5-year median value for Tax Provisions was -$4.0 million (2022), whereas its average is $5.1 million.
  • Within the past 5 years, the most significant YoY rise in Elanco Animal Health's Tax Provisions was 1960000.0% (2024), while the steepest drop was 50000.0% (2024).
  • Over the past 5 years, Elanco Animal Health's Tax Provisions (Quarter) stood at -$15.0 million in 2021, then plummeted by 133.33% to -$35.0 million in 2022, then soared by 140.0% to $14.0 million in 2023, then crashed by 407.14% to -$43.0 million in 2024, then surged by 62.79% to -$16.0 million in 2025.
  • Its Tax Provisions was -$16.0 million in Q3 2025, compared to $14.0 million in Q2 2025 and -$7.0 million in Q1 2025.